In summary, this study uncovers the tumor-suppressive attributes of the aldo-keto reductase AKR1B10 in CRC (phenocopies in GC), where it unleashes PP2A activity through both its redox regulatory capacity and moonlighting, binding-dependent function. The gene discussed is AKR1B10; the disease is neoplasm.